
Cellectis presents way to safer CAR-Ts
The company presented the in vitro "proof-of-concept" of their new CAR-T cells, in which they integrated a gene network that senses tumour...

Inotrem SA raises €39m to provide POC for nangibotide
The Series B round was led by Morningside Ventures with Invus contributing as new investors. Existing investors participating were Andera Partners,...

Lundback swallows migraine drug maker Alder
Alder's first-in-class monoclonal antibody for migraine prevention, eptinezumab, targets the calcitonin gene-related peptide and faces FDA...

Meatable NV raises US$10m in seed funding
BlueYard Capital, the Eurostars Programme of the European Commission, and angel VCs Taavet Hinrikus and Albert Wenger (Union Square Ventures)...

Sanofi buys Synthorx Inc for US$2.35bn
Sanofi SA‘s and Synthorx Inc's Boards approved the deal which forsees that Sanofi will acquire all of the outstanding shares of Synthorx for $68 per...

Boehringer and Zealand to advance obesity drug
Boehringer is collaborating with Danish Zealand Pharma on a long-acting amylin analogue (BI 473494) and a GLP-1/glucagon dual-acting agonist (BI...

Protein protects against liver fibrosis
In mice, a team headed by Philipp Lang from University Düsseldorf, Germany, showed that the iRhom2 protein counteracted the injury- and...